Signaling Through RAS-RAF-MEK-ERK: from Basics to Bedside

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|14|5|601-623

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.5, 2007-02, pp. : 601-623

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DHEA inhibits measles virus through a mechanism independent of its ability to modulate the Raf/MEK/ERK signaling pathway

By Torres Nicolás I   Castilla Viviana   Wachsman Mónica  

Future Virology, Vol. 7, Iss. 11, 2012-11 ,pp. : 1115-1125

Future Medicine

Access to resources Recommend Favorite

RAS/RAF/MEK Inhibitors in Oncology

By  

Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. : 1164-1176

Bentham Science Publishers

Access to resources Recommend Favorite

The MEK1/2 inhibitor U0126 reverses imatinib resistance through down-regulating activation of Lyn/ERK signaling pathway in imatinib–resistant K562R leukemia cells

By Shi R.   Lin J.   Guo Y.   Gong Y.P.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 5, 2014-05 ,pp. : 346-352

Govi-Verlag

Access to resources Recommend Favorite

Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 840-848

Bentham Science Publishers

Access to resources Recommend Favorite

Rat Parathyroid Hormone 1 – 34 Signals through the MEK/ERK Pathway to Induce Cardiac Hypertrophy

By Liu X   Xie R   Liu S  

The Journal of International Medical Research, Vol. 36, Iss. 5, 2008-09 ,pp. : 942-950

Field House Publishing

Access to resources Recommend Favorite